Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HTD1801 in Primary Sclerosing Cholangitis
CTR20200049Phase 2Completed
- Sponsor
- HighTide Therapeutics, Inc.
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of berberine ursodeoxycholate in Primary Sclerosing Cholangitis (PSC), sponsored by HighTide Therapeutics, Inc.. Started Feb 2020; status: completed.
02
Drugs
berberine ursodeoxycholate
03
Conditions
Primary Sclerosing Cholangitis (PSC)
Beyond the preview
Go deeper on CTR20200049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200049.